Literature DB >> 9442490

High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study.

C E Cocuzza1, R Mattina, A Mazzariol, G Orefici, R Rescaldani, A Primavera, S Bramati, G Masera, F Parizzi, G Cornaglia, R Fontana.   

Abstract

A retrospective analysis of susceptibility data available for Group A streptococcal isolates collected between January 1990 and January 1996 at the Hospital Microbiology Laboratory of Monza (North Italy), showed a sharp rise in the erythromycin resistance rates during the last 3 years. Streptococcus pyogenes resistant to erythromycin accounted for approximately 1% of strains isolated between 1990 and 1992; the percentage then rose from 5% in 1993 to almost 39% in 1995. In January 1996, the resistance rates peaked to 81%. A prospective controlled study performed between March and May of 1996 to determine the percentage of erythromycin-resistant Group A streptococci isolated in Monza from untreated children with acute pharyngo-tonsillitis, gave further confirmation of a high rate of erythromycin resistance (47%) in this area. Molecular characterization by T-serotyping and pulse-field gel electrophoresis analysis of 25 erythromycin-resistant Group A streptococcal isolates, showed a relatively high degree of heterogeneity among these strains, demonstrating that the increased resistance is not caused by the spread of a single clone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9442490     DOI: 10.1089/mdr.1997.3.371

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  7 in total

1.  Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada.

Authors:  J C De Azavedo; R H Yeung; D J Bast; C L Duncan; S B Borgia; D E Low
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

2.  Survey of phenotypic and genetic features of streptococcus pyogenes strains isolated in Northwest Italy.

Authors:  Simona Bianco; Tiziano Allice; Mario Zucca; Dianella Savoia
Journal:  Curr Microbiol       Date:  2005-12-26       Impact factor: 2.188

3.  DNA methylase activity as a marker for the presence of a family of phage-like elements conferring efflux-mediated macrolide resistance in streptococci.

Authors:  T A Figueiredo; S I Aguiar; J Melo-Cristino; M Ramirez
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

4.  [Antibiotic sensitivity of important pathogens of bacterial respiratory tract infections in Northeast Germany].

Authors:  O Fierek; P Hinniger; B Panzig
Journal:  Med Klin (Munich)       Date:  1998-11-15

5.  Epidemiology and molecular characterization of Streptococcus pyogenes recovered from scarlet fever patients in central Taiwan from 1996 to 1999.

Authors:  Chien-Shun Chiou; Tsai-Ling Liao; Tzu-Hui Wang; Hsiu-Li Chang; Jui-Cheng Liao; Chun-Chin Li
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

6.  Bacteriological and clinical efficacy of various antibiotics used in the treatment of streptococcal pharyngitis in Italy. An epidemiological study.

Authors:  G Rondini; C E Cocuzza; M Cianflone; A Lanzafame; L Santini; R Mattina
Journal:  Int J Antimicrob Agents       Date:  2001-07       Impact factor: 5.283

7.  Genetic commonality of macrolide-resistant group A beta hemolytic streptococcus pharyngeal strains.

Authors:  Angela L Myers; Mary Anne Jackson; Rangaraj Selvarangan; Richard V Goering; Christopher Harrison
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-12-01       Impact factor: 3.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.